Institute Investigators Receive NHLBI Catalyze Program Grant to Develop Maternal Health Monitoring Technology

UC Irvine Beckman Laser Institute & Medical Clinic researchers Drs. Bernard Choi and Michelle Khine have been awarded a $1.2 million grant from the National Heart, Lung, and Blood Institute (NHLBI) for the project, “Maternal Obstetric Monitoring System (MOMS): a Postpartum Hemorrhage (PPH) Wearable Monitor.”  This award brings the researchers into the NHLBI’s Catalyze Program, a comprehensive translational research support mechanism that provides funding, project management, technical services, and commercialization guidance designed to accelerate the translation of new therapies, devices, and diagnostics to market.

The project aims to develop MOMS, a technology designed to improve early detection of postpartum hemorrhage (PPH), a leading cause of maternal death. By continuously monitoring vital signs, measuring high-quality physiological waveforms, and performing advanced analysis of the measurements, MOMS seeks to identify significant blood loss in new mothers more effectively than current methods, potentially saving lives and improving maternal health outcomes.

The multidisciplinary team – comprising experts in biomedical engineering, obstetrics & gynecology, sociology, and data science – will create a miniaturized, wearable device integrated with multiple sensors.  The device will simultaneously measure continuous blood pressure, heart rate, cardiac output, stroke volume, blood flow, hemoglobin oxygen saturation, and oxygen utilization to facilitate early detection of hypovolemia, or insufficient blood circulation.

The project will deliver a uniquely comprehensive hemodynamic and hemorrhage monitor specifically designed for PPH detection. The team will first finalize their alpha prototype and conduct preliminary validation. The next phase involves refining the technology to create a low-profile, user-friendly beta prototype based on end-user requirements and validated through testing on a diverse population. Data collected will inform predictive algorithm development, culminating in a pilot study with pregnant women during and after delivery.

Upon successful completion, the validated MOMS sensor technology will be ready for both hospital and ambulatory monitoring use during delivery and postpartum care.  MOMS will provide more accurate, precise and robust early indicators of PPH than commercially available technologies, ultimately improving maternal survival rates.

NHLBI’s Catalyze Program enables and expedites the translation of basic science discoveries into new treatments, devices, and diagnostics for patients with heart, lung, blood, and sleep disorders (HLBS).  The program advances potential new medical products through development to the preclinical testing stage by providing research funding, mentoring, advisory services, technology development guidance, regulatory affairs support, commercialization assistance, skills development and education.

About Catalyze

Catalyze’s mission is to provide comprehensive support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates cleared for human testing, while developing a translational research workforce fluent in product development and entrepreneurship.  The organization’s strategies include, funding for HLBS-related therapies, and diagnostics across the translational continuum; supporting scientists in setting achievable milestones that advance projects along the research pathway, educating investigators in translation, marketing, and product commercialization; anticipating researcher needs so they can focus on science rather than project administration; and pivoting funding and support quickly based on evolving project and scientific requirements.

Click here to learn more about Catalyze.

The research described above is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Here’s why your hair turns gray, and what you can do about it

Genetics and age shape the process, but you may have some control over it, too.

By Kathleen Felton, The Washington Post

Whether you’re embracing new silver growths or attacking them strand by strand with tweezers, gray hair is an inevitable part of getting older. “Just as the skin ages and the rest of the organs in your body age, the hair ages, too,” said Helen He, an assistant professor in the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai.

The going-gray process happens at different speeds for different people, she said, but most of us start to notice increasing gray hair sometime in our 30s or 40s, according to the American Academy of Dermatology. Around this time, melanocyte stem cells, which are hair follicle cells responsible for depositing pigment into the hair shaft, can start to become depleted or dysfunctional.

“There’s not really a whole lot known about why the melanocyte stem cells die off,” said George Cotsarelis, chair of the dermatology department at the Perelman School of Medicine at the University of Pennsylvania and a hair-follicle stem-cell researcher. But there are a number of reasons, including stress or DNA damage, “that are thought to maybe prevent these stem cells from surviving,” he said.

The process, called cellular senescence, causes hair to “gradually lose its pigment over time,” He said. Strands that previously were black, brown, red or blond start to emerge from the follicle gray or silver-white. Some people also notice that their gray hair has a coarser texture.

Age remains a major predictor of when a person is likely to go gray. One 2012 study of more than 4,000 participants found that between ages 45 and 65, nearly three-quarters were at least partially gray. But experts increasingly think of this as “more of a dynamic process,” said Natasha Mesinkovska, a dermatologist at UCI Health who has studied hair graying.

Previously, experts viewed graying as something that inevitably happened to hair with age. Newer research suggests “the pattern of pigmentation is more of a live thing than something that’s set in stone,” Mesinkovska said. This means some factors may have more influence over the graying process than you think.

You’ll probably go gray similar to the way your parents did

Genes aren’t the only influence, but they do play a major role. “In the end, that’s what’s determining when you go gray,” Cotsarelis said.

Scientists have discovered genes that seem to have a hand in hair graying and may also affect characteristics such as balding, eyebrow shape and beard thickness. There can be ethnicity differences, too. People who are White tend to go gray earlier than people of African and Asian descent, research has found, and natural blonds may experience a higher percentage of graying sooner.

Premature hair graying — which has not been clearly defined, Cotsarelis said, but is sometimes considered graying before age 20 for Whites, before age 25 for Asians and before age 30 for Black people — also seems to be influenced by genes. One variant, called IRF4, is “strongly linked to earlier graying,” Mesinkovska said. And though rare, certain inherited disorders such as Griscelli syndrome, a condition that causes pigment issues, can result in gray hair from birth.

Men and women are equally likely to go gray, but biological sex might influence where those early gray hairs appear: Men tend to gray around the sideburns and temples, while women often notice graying around the front of the head first.

Lifestyle may influence graying, too

There’s a lot experts still don’t understand about how your lifestyle might affect graying. But some studies have found certain nutritional deficiencies, such as vitamin B12 and iron, are associated with early-onset gray hair. These nutritional deficiencies would probably be severe, though, Cotsarelis said, “not something you’re likely to find too often in the U.S.”

Most people won’t need supplements, he said, but because certain mineral deficiencies have been linked to premature hair graying, it’s wise to make sure your diet checks all of your nutritional boxes.

Stress is also thought to play a role. “It’s always kind of noted that people who are under stress seem to go gray,” said Sarah Millar, a professor in the department of oncological sciences and the dermatology department at Mount Sinai.

2020 study in the journal Nature found that in mice, stress appeared to cause a loss of melanocyte stem cells. When the sympathetic nervous system, also known as the “fight or flight” response, was activated, those melanocyte stem cells seemed to “basically proliferate and differentiate and migrate away from their kind of niche home,” said Millar, who has researched melanocyte stem cells.

That study “was really the first time there’d been a mechanistic link between activation of neurons by stress and the result of hair graying,” she said. “That was very interesting.”

In another 2021 study, researchers from Columbia University Vagelos College of Physicians and Surgeons looked at individual hairs from 14 volunteers, and observed an association between graying and weeks where the participants reported higher levels of stress.

It’s not clear whether reducing stress will slow down the process, however; more research is needed. Still, “I do believe that chronic things exhaust you,” Mesinkovska said, “and that’s why mice studies show — if you bug them nonstop, it will make them go gray.”

Not smoking (a habit known to cause early graying), getting plenty of sleep, minimizing stress, and eating a healthy diet will benefit your overall well-being and possibly support the health of your hair follicles, too. “These are, in general, great habits for antiaging, and part of that involves potentially delaying the hair-graying process,” He said.

That may also include exercise — one study has linked premature graying to a sedentary lifestyle — as well as limiting your alcohol consumption.

Can we slow gray hair progression — or even reverse it?

Other than making lifestyle changes, “there isn’t really a whole lot you can do” about gray strands, Cotsarelis said, other than dyeing your hair or loving your new shade.

At least, not yet: “In the past, the field was really focused on characterizing the changes of melanocyte stem cells,” said Mayumi Ito Suzuki, a professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. “The next step is to understand how to reverse these changes to not have gray hair.”

Some experts have theorized that melanocyte stem cells might essentially become “stuck” in the wrong location during the process of regeneration. “In theory, if healthy stem cells are preserved, hair graying can be transient,” she said.

Her lab, which studies how melanocytes regenerate from stem cells, explored this idea in a 2023 Nature study. Ito’s team observed the localization pattern of stem cells in young and older mice. “If they’re located in a different place somehow during aging, they remain dormant, and don’t produce mature melanocytes,” she said, and in turn don’t produce pigment. Her team is now looking at human samples to see if relocating melanocytes can help prevent the graying process.

There are some over-the-counter topical products that claim to reverse graying, but “none of them have proven efficacy,” He said. Topicals in general are challenging because pigment-producing melanocyte stem cells are in the deepest part of the hair follicle. This is why drugs like Latisse, which do successfully lengthen and darken eyelashes, “just don’t work on the scalp,” Cotsarelis said. “The skin is too thick.”

Some research on potential new treatments “is getting a lot of attention,” Mesinkovska said. A 2023 study from the University of Miami Miller School of Medicine found topical rapamycin may help restimulate melanin. The drug, which is an immunosuppressant used to prevent organ rejection, is not approved by the Food and Drug Administration for this use and is “a fairly potent drug,” Millar cautioned.

If you think you’re experiencing early-onset gray, it’s worth consulting your doctor, Mesinkovska said. “If someone comes to me and says, ‘I have early graying,’ I look for the reason,” she said — while there isn’t always one specific cause that can be fixed, sometimes addressing nutritional deficiencies, a thyroid disorder or inflammation may help, she added.

Since every new hair cycle is an opportunity for a strand to regrow without pigment, “if you’re experiencing a lot of hair loss, you may accelerate the graying,” Cotsarelis said.

Hair loss can’t always be prevented — age, a hereditary disposition and chemotherapy are frequent culprits — but the American Academy of Dermatology recommends minimizing breakage by avoiding treatments such as perms that may damage hair, as well as hairstyles that pull at the scalp.

Stay away from tweezers while you’re at it. “There is a myth that if you pluck out gray hair you’re going to get more gray hairs — that’s not necessarily true, but it’s not an effective strategy,” He said. “More likely than not, the hair that grows out of the follicle next will be gray.”

Click here or visit https://bit.ly/4aPkpCP to read the full The Washington Post article.

Interdisciplinary Skin Science Program

Kristen Kelly, founding director

With a unique collaboration between basic and translational skin scientists, this group will develop the next generation of medications and technologies for treatment of dermatologic disease and advance skin disease diagnosis and monitoring.

UC Irvine’s Interdisciplinary Skin Science Program is one of only six National Institutes of Health-funded Skin Disease Research Core Centers nationwide and, of those, one of only three that also have NIH grants to train future leaders in the field. Its researchers are focused on a range of dermatologic issues, including cancer, inflammatory disorders like psoriasis and eczema, genetic skin disease, cell development and repair, gynecologic skin disease, alopecia (hair loss), and pigmentary disorders like vitiligo and melasma. The program is also known for its work advancing state-of-the-art, noninvasive microscopic imaging.

Now in the Falling Leaves Foundation Medical Innovation Building, seven skin science researchers – with room for one additional future hire – occupy space on the third floor, which is a big step forward for the program, according to founding director Dr. Kristen Kelly, UC Irvine professor and chair of dermatology. The new home base not only brings the skin researchers together but offers important opportunities to collaborate with other groups on the premises. Says Kelly: “It’s really a testament to UC Irvine’s commitment to progress. The impact is going to be better science, which is going to lead to better treatments for patients. I count on seeing significant advances coming from the researchers in this building.”

Click here or visit https://bit.ly/skin-science to view the full article in the Fall 2025 issue of UC Irvine Magazine, “Forging a Brilliant Future.”

OC500 2025: CHRIS BARTY

CHRIS BARTY
CO-FOUNDER/CTO
LUMITRON TECHNOLOGIES INC.
By OCBJ Staff

WHY: Co-founded Irvine-based developer pioneering an ultra-high-intensity, laser-based X-ray system called HyperVIEW for the next generation of cancer treatments.

IN THE NEWS: Lumitron’s X-ray imaging system granted designation of “Breakthrough Device” from FDA in January for its utilization of the K-Edge subtraction technique to improve contrast-enhanced imaging for detecting breast cancer.

NOTABLE: Professor of physics and astronomy at the University of California, Irvine; previously CTO at the National Ignition Facility Directorate at the Lawrence Livermore National Laboratory, where he spent 17 years inventing the core technologies upon which Lumitron’s system is based.

QUOTABLE: “Lumitron’s HyperVIEW laser-Compton X-ray source is an alternative to traditional X-ray tubes that can provide images with significantly greater clarity and accuracy. These capabilities can both enable more reliable detection and reduce the dose of radiation received by the patient.”

Click here or visit https://bit.ly/oc500-barty to read full article on the Orange County Business Journal website.

Professor Eric Potma receives $1.3 million grant from NIH

The funding will support Potma’s research into biosensing technologies.

By: Lucas Van Wyk Joel | UC Irvine Physical Sciences Communications | Photo Credit: S. Mahmoodi

Professor Eric Potma of the UC Irvine Department of Chemistry has received a $1.3 million grant from the National Institute of Health to support research into biosensing technologies. The project is a collaboration between Potma and Professor Maxim Shcherbakov of the UC Irvine School of Engineering, aimed at developing sensors that can detect and identify individual molecules at speeds of up to one million measurements per second. “Currently, there are no existing techniques that can reach such detection limits,” said Potma, who explained how the technology stands to revolutionize many different fields, from drug development to genetic screening. “Our platform enables the discovery of enzymatic reaction dynamics, which can be leveraged to engineer enzymes for producing drugs. It could also pave the way for faster sequencing of DNA, introducing new possibilities for accelerating genomic screening.” Initially, the funding will help Potma and Shcherbakov design the new platform using computer simulations, followed by the fabrication and testing of sensor materials. “We will extensively test and characterize the performance of our fabricated silicon metasurfaces, and iteratively optimize them so that the desired performance is reached,” Potma said.

Click here or visit https://ps.uci.edu/news/3402 to read full new brief on the UC Irvine School of Physical Sciences website.

Lighting the way

How watching a baseball game led to a discovery that made laser surgery possible

The concept that revolutionized laser surgery and earned UC Irvine nearly $60 million came to Dr. J. Stuart Nelson in 1992 while he was watching a baseball game.

In the early 1990s, surgeons like Nelson were attempting to adapt laser technology for medical use, and the Beckman Laser Institute & Medical Clinic served as an epicenter for this effort. It was, at the time, the only facility in the world to house basic science and engineering labs and an outpatient clinic under one roof, letting researchers and surgeons quickly translate findings into patient-care breakthroughs.

As medical director of the BLIMC, Nelson had been striving to improve laser treatments for disfiguring vascular birthmarks, such as port-wine stains, in infants and young children. Laser’s utility was limited because its intense light also injured the fragile top layer of skin, causing pain, scarring and pigmentation changes. The challenge was to find a way to protect the outer skin while maximizing the destruction of the deeper blood vessels that create a birthmark.

Nelson and his BLIMC colleagues at the time – postdoctoral researcher Thomas Milner and visiting Norwegian engineer Lars Svaasand – had tried using ice cubes, running cold water and even the application of chilled metal plates to cool the skin’s superficial layer before laser exposure. Unfortunately, all of these methods proved too cumbersome and, more importantly, also cooled the targeted blood vessels, which inhibited the laser’s effectiveness.

“We needed to get something very cold onto the skin surface in perfect thermal contact and then off the skin surface – all within a fraction of a second,” Nelson said. “I remembered what I saw watching a baseball game.”

Over a Friday night dinner at the former Rusty Pelican restaurant in Irvine, he told his colleagues how, when a batter fouled a baseball off his foot or ankle, a trainer would emerge from the dugout and spray ethyl chloride onto the injury site to numb the pain. The three agreed that spray cooling might be effective with lasers if the cryogenic agent evaporated very quickly and, therefore, only affected the topmost layer of skin.

During the weekend, Milner and Svaasand hashed out ideas on how this concept could work; on Monday, they went to Pep Boys and purchased a Toyota Camry fuel injector valve, a hose clamp and air conditioning coolant to build the first prototype of the Dynamic Cooling Device.

To determine the optimal cryogen spurt duration and interval between spurt termination and laser exposure, all three researchers tested the DCD on themselves. “We still have scars on our arms to prove it,” Nelson said.

“It was a fairly simple construction,” said Milner, who is now the Olga Keith Wiess Professor of Surgery and director of the Michael E. DeBakey Center for Nano-Biophotonics at the Baylor College of Medicine in Houston. “That’s the beauty of the invention: It’s so simple and works so well.”

The device is incorporated into the laser’s handpiece and sprays a nonflammable, environmentally compatible freon substitute onto the skin surface, forming a liquid pool with a temperature of -60 degrees Celsius. This pool almost immediately evaporates, and milliseconds later, the skin is exposed to the laser. The process is repeated before each pulse of light.

“Because the spurt durations are so short, the cooling remains confined to the skin’s most superficial layer and does not affect the deeper targeted blood vessels causing the vascular birthmark,” Nelson explained. “This allows much higher laser light dosages to be used, while at the same time minimizing injury to the skin and pain to the patient.”

The DCD was patented in September 1998 and subsequently licensed to Candela Laser Corp. for commercial development and marketing. The patent expired in 2020. It’s now standard on more than 47,000 Candela lasers sold worldwide, as well as on the lasers of other companies around the world.

Between 2001 and 2010, the device was among the 10 top-earning licensed inventions in the University of California system – and in 2005 and 2006, it ranked second and third, respectively. To date, the DCD generated nearly million in royalties for UC Irvine.

“The combination of basic research, engineering and clinical testing that went into the Dynamic Cooling Device is exactly what was envisioned over 30 years ago when the idea of the BLIMC was first conceived,” said Michael Berns, the Arnold & Mabel Beckman Chair in Laser Biomedicine and institute co-founder, to ZotZine in 2011.

While DCD-equipped lasers are utilized for several cosmetic procedures – the removal of unwanted hair, scars and rosacea, for example – Nelson is pleased that his invention primarily benefits individuals born with port-wine stains. At the BLIMC’s world-renowned Vascular Birthmarks & Malformations Diagnostic & Treatment Center, he has handled more than 20,000 such cases.

A surgeon at the Beckman Laser Institute & Medical Clinic treats an 8-month-old’s port-wine stain with a DCD-equipped laser.
A surgeon at the Beckman Laser Institute & Medical Clinic treats an 8-month-old’s port-wine stain with a DCD-equipped laser. Steve Zylius / UC Irvine

“The technology has made possible the early, painless, safe and effective treatment of port-wine stains and other disfiguring vascular birthmarks in infants and young children in ways that Tom, Lars and I could never have imagined,” Nelson said. “That’s what I’m most proud of.”

Updated from the original story published in ZotZine Vol. 4, Iss. 2

Click here or visit https://bit.ly/nelson-lighting to read the full article in UC Irvine News.

Howard Lee selected as Moore Experimental Physics Investigator to develop revolutionary nanoscale electron accelerator

Lee’s research could transform cancer treatment and medical technologies

Tatiana Overly | UC Irvine School of Physical Sciences

Professor Howard Lee in the UC Irvine Department of Physics & Astronomy has been named a 2025 Experimental Physics Investigator by the Gordon and Betty Moore Foundation. The funding will support Lee in advancing groundbreaking research in nanoscale electron acceleration technology.

Lee is developing the world’s first nanoscale electron accelerator by merging advanced nano-optical materials and nanostructures with laser wakefield acceleration. Unlike traditional accelerators such as the Large Hadron Collider that require extensive long well-defined channels, Lee’s apparatus uses nanoscale solid-state materials and high-power ultrafast lasers to accelerate electrons and generate X-rays.

“This award is significant since it allows me to pursue an entirely new research direction not previously explored,” Lee said. “Given the current funding climate, the opportunity to support research with bold new ideas is truly game-changing for my group, allowing us to further advance optical science and technology. I am deeply grateful to the Moore Foundation for their generous support.”

Lee’s work could enable new medical therapies, including laser wakefield accelerator optical fiber endoscope probe and free electron laser devices for next-generation biomedical and imaging technologies. When integrated into optical fibers, these nanoscale accelerators could open transformative biomedical applications, including advanced cancer treatments.

The research has significant implications across multiple scientific disciplines, including nano- and nonlinear optics, plasma physics, particle physics, and biophysics. Beyond its practical applications, the research promises fundamental insights into utilizing nanoscale metasurfaces for particle acceleration and could create an entirely new class of light-matter phenomena.

“The year 2025 is a particularly special one for me, as I was promoted to Full Professor at UC Irvine, elected as an Optica Fellow, and now selected as a Moore Experimental Physicist,” said Lee. “I am deeply grateful to my former postdoc advisor, Harry Atwater at Caltech, and my Ph.D. advisor, Philip Russell at the Max Plank Institute for the Science of Light, for their invaluable guidance throughout my academic journey and for serving as inspiring role models in pursuing optical science and photonic technology as a career.” Lee also thanks UC Irvine and his colleague, Professor Toshiki Tajima, a leading theoretical physicist in laser wakefield acceleration, who first introduced him to this field of research.

The Gordon and Betty Moore Foundation advances scientific discovery, environmental conservation, and the special character of the San Francisco Bay Area. Visit moore.org and follow @MooreFound. 

Click here or visit https://bit.ly/ps-lee-cancer-treatment to read full article on the UC Irvine School of Physical Sciences website.

Advancing Discovery: 2025 Experimental Physics Investigators

The 2025 cohort of Experimental Physics Investigators is a distinguished group of mid-career researchers pushing the boundaries of experimental physics. These 22 new investigators are joining the scientists from three previous cohorts in advancing the frontier of fundamental research in experimental physics. Regarding the magnitude and size of the award, 2024 investigator Shimon Kolkowitz remarked, “this is exactly what we needed to attempt our complex experiments, and it is especially important given the current uncertainties in federal funding in the United States.”

The Experimental Physics Investigators Initiative provides $1.3 million over five years to give these scientists flexibility to accelerate breakthroughs and strengthen the experimental physics community.

“We once again received proposals from amazing mid-career investigators who are taking their research to new levels,” said Theodore Hodapp, program director for the initiative. “We are excited to see them join our existing cohorts of experimental physicists who are pushing the boundaries of our understanding of the universe.”

Among this year’s investigators are:

  • Howard Lee from University of California, Irvine who is building the first nanoscale accelerator capable of producing high-energy electrons, with applications in plasma and particle physics as well as biomedcine.
  • Jaideep Taggart Singh from the Facility for Rare Isotope Beams at Michigan State University who is developing an experimental platform to search for time-reversal-violating forces, potentially explaining why the universe contains more matter than antimatter.
  • Adina Luican-Mayer from University of Illinois Chicago who is studying moiré-induced polarization in atomically thin materials, work that could uncover new phases of matter and enable ultra-compact, energy-efficient electronics.

Cultivating collaborative research environments that welcome all students and promote highly effective research teams is a goal of the initiative. Awardees pursue this goal in different ways. For example, Professor Singh will use part of the funding to design unique trainings for students at the intersection of different disciplines including atomic, molecular, optical and nuclear physics.

“To connect investigators and promote the discovery of new ideas and synergistic collaborations, we bring all cohorts together each year in a relaxed setting,” remarked Catherine Mader, program officer for the initiative. “We have seen numerous new connections form and new research directions pursued by both individuals and groups based on conversations at these gatherings.”

Meet the 2025 Experimental Physics Investigators 

The foundation is now accepting applications for the 2026 cohort of Experimental Physics Investigators. The deadline to apply is October 14, 2025. Apply for the 2026 cohort.

Click here or visit https://bit.ly/advancing-discovery to read full article on the Gordon and Betty Moore Foundation website.

Reshaping Eyeballs With Electricity, No Lasers Or Cutting Required

By Lewin Day, Hackaday

Glasses are perhaps the most non-invasive method of vision correction, followed by contact lenses. Each have their drawbacks though, and some seek more permanent solutions in the form of laser eye surgeries like LASIK, aiming to reshape their corneas for better visual clarity. However, these methods often involve cutting into the eye itself, and it hardly gets any more invasive than that.

A new surgical method could have benefits in this regard, allowing correction in a single procedure that requires no lasers and no surgical cutting of the eye itself. The idea is to use electricity to help reshape the eye back towards greater optical performance.

THE EYES HAVE IT

Existing corrective eye surgeries most often aim to fix problems like long-sightedness, short-sightedness, and astigmatism. These issues are generally caused by the shape of the cornea, which works with the lens in the eye to focus light on to the light-sensitive cells in the retina. If the cornea is misshapen, it can be difficult for the eye to focus at close or long ranges, or it can cause visual artifacts in the field of view, depending on the precise nature of the geometry. Technologies like LASIK reshape the cornea for better performance using powerful lasers, but also involve cutting into the cornea. The procedure is thus highly invasive and has a certain recovery time, safety precautions that must be taken afterwards, and some potential side effects. A method for reshaping the eye without cutting into it would thus be ideal to avoid these problems.

Enter the technology of Electromechanical Reshaping (EMR). As per a new paper, researchers at the University of California, Irvine, came across the idea by accident, having been looking into the moldable nature of living tissues. As it turns out, collagen-based tissues like the cornea hold their structure thanks to the attractions between oppositely-charged subcomponents. These structures can be altered with the right techniques. For example, since these tissues are laden with water, applying electricity can change the pH through electrolyzation, altering the attraction between components of the tissue and making them pliable and reformable. Once the electric potential is taken away, the tissues can be restored to their original pH balance, and the structure will hold firm in its new form.

Researchers first tested this technique out on other tissues before looking to the eye. The team were able to use EMR to reshape ears from rabbits, while also being able to make physical changes to scar tissue in pigs. These efforts proved the basic mechanism worked, and that it could have applicability to the cornea itself.

To actually effectively reshape the cornea using this technique, a sort of mold was required. To that end, researchers created a “contact lens” type device out of platinum, which was formed in the desired final shape of the cornea. A rabbit eyeball was used in testing, doused in a saline solution to mimic the eye’s natural environment. The platinum device was pushed on to the eye, and used as an electrode to apply a small electrical potential across the eyeball. This was controlled carefully to precisely change the pH to the region where the eye became remoldable. After a minute, the cornea of the rabbit eyeball had conformed to the shape of the platinum lens. With the electrical potential removed, the pH of the eyeball was returned to normal and the cornea retained the new shape. The technique was trialled on twelve eyeballs, with ten of those treated for a shortsightedness condition, also known as myopia. In the case of the myopic eyeballs, all ten were successfully corrected the cornea, creating improved focusing power that would correspond to better vision in a living patient’s eye.

While the technique is promising, great development will be required before this is a viable method for vision correction in human patients. Researchers will need to figure out how to properly apply the techniques to eyeballs that are still in living patients, with much work to be done with animal studies prior to any attempts to translate the technique to humans. However, it could be that a decade or two in the future, glasses and LASIK will be increasingly less popular compared to a quick zap from the electrochemical eye remoulder. Time will tell.

Click here or visit https://bit.ly/reshaping-eyeballs to read the full article on Hayaday.com.

Pioneering Light-Based Innovation: New Faculty Join the Institute

Two distinguished researchers bring cutting-edge expertise in optical diagnostics and computational imaging to advance biomedical applications

UC Irvine Beckman Laser Institute & Medical Clinic welcomes two talented new faculty members whose groundbreaking research in optical technologies promises to revolutionize both clinical diagnostics and neuroscience imaging. Drs. Abraham Qavi and Fei Xia join the institute’s renowned interdisciplinary community, bringing complementary expertise that bridges science, engineering, and medicine.

ABRAHAM QAVI: TRANSFORMING CLINICAL DIAGNOSTICS THROUGH ADVANCED OPTICS

Dr. Abraham Qavi joins the Institute as Assistant Professor in Residence of Pathology and Chemistry, bringing a unique combination of clinical expertise and pioneering research in optical diagnostics. As a board-certified pathologist, Dr. Qavi currently serves multiple leadership roles at UC Irvine Medical Center, including Director of Point of Care Testing, Director of Innovative Laboratory Diagnostics, and Associate Director of Clinical Chemistry.

Revolutionary Diagnostic Technologies

Dr. Qavi’s research program leverages sophisticated optical technologies to address critical gaps in clinical diagnostics. His laboratory specializes in photonic resonators and plasmonic-enhanced sensors—advanced techniques that enable precise control and manipulation of light to dramatically improve diagnostic sensitivity and speed.

“Dr. Qavi’s work represents the future of diagnostic medicine,” states Dr. Bernard Choi, Institute Interim Director. “By harnessing the intrinsic properties of light, his research enables ultrasensitive detection capabilities that could transform how we diagnose and monitor disease.”

Dr. Qavi’s research focuses on two primary technological platforms:

Photonic Resonators: These exquisitely sensitive optical devices exploit light confinement principles to achieve unprecedented detection limits. By trapping light in microscopic cavities, photonic resonators can detect minute changes in their optical environment when target molecules bind to their surfaces. This enables detection of viral particles, proteins, or other biomarkers at concentrations far below what conventional tests can achieve.

Plasmonic Enhancement: Dr. Qavi utilizes the unique optical properties of metallic nanoparticles, particularly gold nanostructures, which can concentrate light into extremely small volumes and amplify optical signals. When light interacts with these specially designed nanoparticles, it creates intense electromagnetic fields that dramatically enhance the detection of nearby molecules.

Clinical Applications and Global Impact

Dr. Qavi’s studies have demonstrated efficacy in rapid viral detection, including filoviruses, such as Ebola, and coronaviruses. His platforms can potentially reduce diagnostic time, while maintaining or exceeding the accuracy of traditional laboratory methods.

This potential extends beyond modern healthcare systems. The low-cost, high-throughput nature of plasmonic sensors makes them particularly valuable for addressing neglected tropical diseases in resource-limited settings, where rapid, accurate diagnosis can be lifesaving.

Dr. Qavi’s research areas include ultrasensitive pathogen detection using photonic resonators, point-of-care diagnostic platforms for global health applications, integration of advanced optics with clinical laboratory workflows and the development of laboratory-developed tests (LDTs) for personalized medicine.

Clinical Foundation

Dr. Qavi earned his medical degree from the University of Illinois College of Medicine in Chicago and completed his residency in clinical pathology at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. This strong clinical foundation informs his research approach, ensuring that technological innovations address real-world medical needs.

Click here or visit https://bli.uci.edu/abraham-qavi/ to learn more about Dr. Qavi.

FEI XIA: COMPUTATIONAL PHOTONICS FOR ADVANCED BIOMEDICAL IMAGING

Dr. Fei Xia, Assistant Professor of Electrical Engineering and Computer Science, brings pioneering expertise at the intersection of optics, computation, and neuroscience. Her research centers on developing revolutionary optical systems that image, sense, and process biomedical information through groundbreaking light-based technologies.

Dr. Xia’s research centers on two approaches:

Advanced Optical Systems: Dr. Xia develops sophisticated imaging platforms that can capture biological information across multiple spatial and temporal scales simultaneously. These systems often incorporate adaptive optics, multi-modal detection, and real-time feedback control to optimize image quality for specific applications.

Computational Enhancement: Her laboratory develops machine learning algorithms and signal processing techniques specifically designed to extract maximum information from optical measurements. These computational approaches can reveal patterns and structures that would be invisible to conventional analysis methods.

Precision Imaging for Neuroscience

Dr. Xia’s research program focuses on enhancing imaging precision across spatial (seeing smaller structures) and temporal dimensions (capturing faster processes) to unlock new possibilities in biomedical imaging. Her laboratory is particularly dedicated to brain imaging, recognizing the brain’s critical role as both a regulator of health and the source of human intelligence.

Dr. Xia’s current applications include high-resolution imaging of neural networks in living tissue, real-time monitoring of brain activity during cognitive tasks, early detection of neurodegenerative diseases, and the development of precision tools for neurosurgical planning.

“Through the strategic co-design of hardware and software solutions, Dr. Xia addresses complex biomedical challenges and advances our understanding of living biological systems,” states Dr. Choi. “Her work drives the development of more precise diagnostic tools and discovery platforms that advance both neuroscience research and neurological medicine.”

Global Research Perspective

Dr. Xia’s contributions have earned multiple prestigious awards, including the 2024 Rising Star in Light Award and 2023 Optica Foundation Challenge Award, recognizing her as a leader in the next generation of optical scientists.

Dr. Xia brings a strong international research background, having completed her Ph.D. at Cornell University and postdoctoral research at École Normale Supérieure (ENS) in Paris, France. Her diverse educational experience across three continents – undergraduate studies in China, doctoral work in the USA, and postdoctoral research in France – provides a unique global perspective.

Click here or visit https://bli.uci.edu/fei-xia/ to learn more about Dr. Xia.

LOOKING FORWARD

Drs. Qavi and Xia’s work promises to advance the frontiers of optical technologies in biomedicine. From revolutionizing point-of-care diagnostics to unlocking new insights into brain function, their research represents the cutting-edge of light-based innovation to impact human health.